United Therapeutics Corp. (NASDAQ:UTHR) CEO Martine Rothblatt sold 3,833 shares of United Therapeutics Corp. stock in a transaction that occurred on Thursday, January 9th. The shares were sold at an average price of $108.35, for a total value of $415,305.55. Following the completion of the transaction, the chief executive officer now directly owns 140 shares […]
Insider Selling: United Therapeutics Corp. CEO Sells 3,833 Shares of Stock (UTHR) is a post from: Zolmax
The post Insider Selling: United Therapeutics Corp. CEO Sells 3,833 Shares of Stock (UTHR) appeared first on Zolmax.